↓ Skip to main content

Cochrane Database of Systematic Reviews

Intravenous secretin for autism spectrum disorders (ASD)

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet
blogs
6 blogs
twitter
6 X users
patent
43 patents
facebook
1 Facebook page
wikipedia
5 Wikipedia pages

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
267 Mendeley
Title
Intravenous secretin for autism spectrum disorders (ASD)
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd003495.pub3
Pubmed ID
Authors

Katrina Williams, John A Wray, Danielle M Wheeler

Abstract

In 1998 secretin, a gastrointestinal hormone, was suggested as an effective treatment for autism spectrum disorders (ASD) based on anecdotal evidence.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 267 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Mexico 1 <1%
Unknown 264 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 39 15%
Researcher 36 13%
Student > Bachelor 27 10%
Student > Ph. D. Student 23 9%
Student > Postgraduate 20 7%
Other 61 23%
Unknown 61 23%
Readers by discipline Count As %
Medicine and Dentistry 65 24%
Psychology 40 15%
Nursing and Health Professions 25 9%
Social Sciences 12 4%
Neuroscience 12 4%
Other 37 14%
Unknown 76 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 58. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2023.
All research outputs
#725,756
of 25,390,203 outputs
Outputs from Cochrane database of systematic reviews
#1,368
of 12,712 outputs
Outputs of similar age
#3,342
of 171,731 outputs
Outputs of similar age from Cochrane database of systematic reviews
#10
of 179 outputs
Altmetric has tracked 25,390,203 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,712 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 36.6. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 171,731 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 179 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.